Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
83 78 88 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
Insufficient record: 2 predictions resolved, 5 needed for a score.
-
Promises
Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
Insufficient record: 0 promises resolved, 5 needed for a score.
All types combined: 83 (likely 78 to 88, high confidence), from 86 claims: 86 factual claims. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Daniela Amodei's claims
44 claims
“In the Democratic Republic of the Congo, Claude is helping the teams responding to a rare and deadly strain of Ebola.”
Daniela Amodei, Anthropic co-founder and president, foreword 21 October 2026 Anthropic 2026 Public Benefit Report: Taking stock of our progress (foreword by Daniela Amodei) (Anthropic)
In the Democratic Republic of the Congo, Claude is helping teams respond to a rare and deadly strain of Ebola.
Unresolvable The public record could not settle it.
The second judge would not resolve this claim; the verdict shown is the first judge's.
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
Judge as of 21 Oct 2026. True if credible evidence shows that, at or shortly before that date, organisations responding to an Ebola outbreak in the DRC (health ministry, WHO, NGOs, or partners) were using Claude in that response, and that the outbreak involved a rare or uncommon strain (for example a species other than Zaire ebolavirus, such as Bundibugyo or Sudan) that was deadly. Mostly true if Claude was used in the DRC Ebola response but the strain detail is slightly off (for example a common strain described as rare), or the use was by a single partner organisation. Mixed if Claude was used only in Ebola-related work outside the active field response (for example general research), or if there was no active outbreak at the time. Mostly false if Claude's use was only planned or piloted and not deployed. False if there is no Ebola outbreak response in the DRC involving Claude, as shown by responder or partner accounts that describe the tools used and leave Claude out.
Evidence
- AI in healthcare: from fighting epidemics to family doctors Euronews · 15 October 2026
“Since May, teams on the ground in the Democratic Republic of Congo (DRC) have been fighting the Bundibugyo strain of the Ebola virus.”
- AI in healthcare: from fighting epidemics to family doctors Euronews · 15 October 2026
“To evaluate the answers and reports, Anthropic's Claude model was used. Among those involved in the study were CEPI, the WHO Regional Office for Africa and the national biomedical research institute INRB.”
- WHO Health Emergencies EPI-WIN webinar: Update on the current Ebola Bundibugyo virus disease outbreak World Health Organization · 1 November 2026
“As of 31 October 2026, a total of 10,467 confirmed cases and 5,103 deaths had been reported across 67 health zones in eight provinces, with the outbreak surpassing the 10,000-case mark.”
- The Situation Report Anthropic · 19 September 2026 Own record
“Since May, teams on the ground in the Democratic Republic of the Congo (DRC) have been combating a rare strain of Ebolavirus called Bundibugyo (BDBV).”
Reasoning
The evidence shows an active Bundibugyo Ebola outbreak in the DRC (E1, E3, E4) and that Claude was used to evaluate answers and reports in a study involving CEPI, the WHO Regional Office for Africa and INRB (E2). It does not show whether that use was part of the active field response or separate research, and the criteria treat those cases differently.
Cite this claim
Daniela Amodei, “In the Democratic Republic of the Congo, Claude is helping teams respond to a rare and deadly strain of Ebola.” (said 21 October 2026). Verdict: unresolvable. Reliability API, claim c_bfa7bbf8e1c8, method 0.1.0+28da144b. https://epistacklabs.com/claims/c_bfa7bbf8e1c8
Claims without a verdict
Is a verdict here wrong, or do you speak for Daniela Amodei? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.